Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.5, 2010-05, pp. : 663-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

By Yau Thomas Pang Roberta Chan Pierre Poon Ronnie T

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2187-2198

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies in Hepatocellular Carcinoma

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-03 ,pp. : 966-974

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

By Keating Gillian M.

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 223-240

Adis International

Access to resources Recommend Favorite